Literature DB >> 15766975

Renoprotective therapy: is it blood pressure or albuminuria that matters?

Paul E De Jong1, Dick de Zeeuw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15766975     DOI： 10.1016/S0140-6736(05)71055-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Heart rate variability predicts ESRD and CKD-related hospitalization.

Authors:  Daniel J Brotman; Lori D Bash; Rehan Qayyum; Deidra Crews; Eric A Whitsel; Brad C Astor; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

Review 2.  Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.

Authors:  Luis Miguel Ruilope; Josep Redón; Roland Schmieder
Journal:  Vasc Health Risk Manag       Date:  2007

3.  Study of the association between the donors and recipients angiotensin-converting enzyme insertion/deletion gene polymorphism and the acute renal allograft rejection.

Authors:  Jalal Azmandian; Mohamadamir Mohamadifar; Sara Rahmanian-Koshkaki; Mohammad Mehdipoor; Mohamad-Hadi Nematollahi; Amin Saburi; Ali Mandegary
Journal:  J Nephropathol       Date:  2015-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.